Aminophylline for bradyasystolic cardiac arrest in adults

Keyphrases

• Cardiac Arrest 100%
• Aminophylline 100%
• Risk Ratio 40%
• Confidence Interval 30%
• Survival to Discharge 30%
• Subgroup Analysis 20%
• Adverse Events 20%
• Neurological Outcome 20%
• Survival to Admission 20%
• Return of Spontaneous Circulation 20%
• Placebo 10%
• Hospital Admission 10%
• Randomized Controlled Trial 10%
• Non-associated 10%
• MEDLINE 10%
• Embase 10%
• Hospital Discharge 10%
• Effects on Survival 10%
• CINAHL 10%
• Selection Criteria 10%
• Risk of Bias 10%
• Search Methods 10%
• Review Update 10%
• Review Authors 10%
• Cochrane Central Register of Controlled Trials 10%
• Conference Proceedings 10%
• Survival Outcomes 10%
• Atropine 10%
• Google 10%
• Resuscitation 10%
• Resuscitative 10%
• Catecholamines 10%
• Non-traumatic 10%
• International Clinical Trials Registry Platform (ICTRP) 10%
• Early Administration 10%
• Adenosine 10%
• Adenosine Receptor Antagonists 10%
• Advanced Cardiac Life Support 10%
• Normothermic 10%
• Lilac 10%
• Prehospital Setting 10%
• Cardiac Ischemia 10%

Medicine and Dentistry

• Heart Arrest 100%
• Aminophylline 100%
• Adverse Event 20%
• Subgroup Analysis 20%
• Resuscitation 20%
• Return of Spontaneous Circulation 20%
• Placebo 10%
• Randomized Controlled Trial 10%
• Clinical Trial 10%
• Heart Muscle Ischemia 10%
• Adenosine Receptor Antagonist 10%
• Catecholamine 10%
• Adenosine 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Heart Arrest 100%
• Aminophylline 100%
• Adverse Event 20%
• Placebo 10%
• Randomized Controlled Trial 10%
• Clinical Trial 10%
• Adenosine 10%
• Heart Muscle Ischemia 10%
• Adenosine Receptor Blocking Agent 10%
• Catecholamine 10%